Medical Devices & Tech


201 Technology Drive
Irvine, CA 92618 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Minimally Invasive Technology for Tissue and Tumor Ablation

Management Terrence A. Noonan, Director, Interim CEO & Interim President; Michael Rodriguez, CFO; Clint B. Davis, Senior Vice President, Legal Affairs, General Counsel and Secretary

Click here for Financial Data
Keywords: cancer, urological, surgery products, urology, prostate, urinary, bladder, erectile, advamed, cryotherapy, renal, pain, management, ablation, kidney, liver, lung, cryoablation, minimally invasive, metastases, palliative intervention


Updated: Aug. 22, 2013


Endocare, Inc. is developing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing cryoablation (freezing) technologies for the treatment of ......view more

Products / Services

Cryoablation is a minimally invasive means of destroying cancerous and other target tissues in a non-toxic manner without the use of open surgery, radiation or dangerous chemicals. Cryocare CS is a fu......view more

Technology / Differentiation

One key element of the FDA-cleared Cryocare CS system is the AutoFreeze, a computer-controlled automated freezing mechanism that utilizes optimal power settings based upon target endpoint temperatures...view more

Market / Customers

Endocare's cryoablation technology platforms are marketed and sold by a direct-sales force to urologists and interventional radiologists. To date, the majority of sales have been to physicians for med......view more


Endocare announced that it had agreed to merge with Israel-based Galil Medical in November 2008, a move that will result in a company with approximately $55 million in TTM revenues....view more

Analyst Coverage